Companies including Pfizer and Johnson & Johnson have said they each aim to produce as many as 1 billion doses by the end of 2021.
Read MoreHere is the latest update on COVID-19 vaccines from different pharmaceutical companies
Read MoreThe potential treatment is the fourth early-stage COVID-19 drug to show promise in human testing, along with projects involving Moderna, CanSino Biologics and Inovio Pharmaceuticals.
Read More"We're very happy that we're seeing the right sort of immune response that will give protection, and not the wrong sort," Gilbert said.
Read MoreCipla's version is priced at less than 5,000 Indian rupees ($66.24), while Hetero Lab's version is priced at 5,400 rupees ($71.54).
Read MoreThe indigenous, inactivated vaccine developed and manufactured in the company's Bio-Safety Level 3 (BSL-3) High Containment facility located in Genome Valley, Hyderabad.
Read MoreThe investors are in for an early reckoning because BioNTech has said it expects first clinical data on its COVID-19 vaccine development programme known as BNT162 this month or in July.
Read MoreChina's Central Military Commission approved the use of the vaccine by the military on June 25 for a period of one year,
Read More